Craig, Kayla
Craig, Kayla was paid $735K by Medicaid between Jul 2022 and Jul 2024, across 22 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoCRAIG, KAYLA
BETHALTO, IL 62010
BETHALTO, IL 62010
33aNPI1457977274assigned 06/17/2020
33bProvider typeRegistered Nurse
28Total paid$735K
24GClaims18,841
24DCodes billed22
24AFirst – last monthJul 2022 – Jul 2024
Compared with peers
Next to other Registered Nurse providers in Illinois
Rank by total paid#7 of 486
Median peer was paid$19K
This provider vs. median38×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 3,141 | $130K | |
| 2023 | 10,714 | $406K | |
| 2024incomplete | 4,986 | $199K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 3,267 | 2,971 | $209K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 3,807 | 3,455 | $165K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 14% | 1,329 | 1,259 | $104K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 10% | 1,661 | 1,608 | $76K |
| 99000 | 6.1% | 1,986 | 1,822 | $45K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.1% | 1,074 | 913 | $37K |
| 87428 | 4.4% | 515 | 487 | $32K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.2% | 1,531 | 1,397 | $24K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.7% | 779 | 614 | $20K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 768 | 610 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 70 | 63 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 63 | 53 | $2K |
10 more codes
| 81002 | <1% | 827 | $2K | |
| 87210 | <1% | 412 | $2K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 41 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 24 | $2K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 69 | $372.89 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 149 | $310.28 |
| 81025 | <1% | 61 | $310.20 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 232 | $239.24 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 18 | $111.69 |
| 36415 | Collection of venous blood by venipuncture | 0% | 158 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.